Portfolio Update

Finsbury Worldwide Pharm Tst PLC
02 July 2004



                                                                     2 July 2004



                             FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC
                                           (the 'Company')


                                  QUARTERLY STATEMENT OF INVESTMENTS


In compliance with the Listing Rules - Chapter 21 Investment Entities (I)(ii),
the Company discloses the following:



  • Investments valuing greater than 5% of the Company's gross assets comprise
    the following:


Company Name                                                        Value of Investment at      % of Total
                                                                         30 June 2004        Portfolio  Assets
                                                                         
Genentech Inc                                                             16,297,734               7.16
Pfizer                                                                    12,286,738               5.40





  • The ten largest investments held by the Company comprise the following:


Company Name                                                         Value of Investment at      % of Total
                                                                         30 June 2004         Portfolio Assets
                                                                   

Genentech Inc                                                              16,297,734               7.16
Pfizer                                                                     12,286,738               5.40
Novartis                                                                   11,248,696               4.94
Lilly (Eli) & Company                                                      10,793,934               4.74
Altana AG                                                                  10,693,368               4.70
Genzyme Corp General Division                                              10,429,556               4.58
Schering-Plough Corporation                                                10,190,240               4.48
Amgen                                                                      10,063,347               4.42
Medimmune Inc                                                              9,464,127                4.16
Given Imaging                                                              9,457,968                4.16







                                    - ENDS -



For further information please contact:

Tracey Lago, Company Secretary

Close Finsbury Asset Management Limited

Telephone: [phone]


                      This information is provided by RNS
            The company news service from the London Stock Exchange  ND

PFUILFFRDSIFIIS